Current Clinical Trials:
COVID‑19 Antiviral Research Study
Upcoming Clinical Trials:
TYDAL Cardiovascular Disease Study
Current Clinical Trials
COVID‑19 Antiviral Research Study
Learn about the Clementine Trial, exploring a potential new antiviral treatment for people who are 75+ or 18+ and immunocompromised who have tested positive for COVID‑19.
Click image to download PDF
Why Participate?
- Help researchers develop new antiviral treatments for those who can’t access current options.
- All participants receive close medical support.
See If You Qualify
For more info and to see if you qualify, please get in touch with us below.
Who Can Take Part?
- Adults aged 18+ with confirmed COVID‑19
and at risk of severe illness, including:
- People aged 75+
- Current or recent cancer treatment
- Diabetes, heart, lung, or kidney conditions
- On immunosuppressive medications
- Have COVID‑19 but can’t access Paxlovid?
- Start study treatment within 4 days of symptom onset.
What’s Involved?
- Take oral medication (or placebo) twice daily for 5 days.
- 6 in‑clinic visits + phone follow‑ups.
You may be eligible for a clinical trial of a potential new COVID‑19 antiviral treatment.
Pacific Clinical Research Network (PCRN)
Silverdale Medical is recruiting participants who test positive for COVID‑19 but are not eligible for existing approved treatments like Paxlovid.
We can arrange to see unwell COVID‑positive patients the same day.
Contact Us
Upcoming Clinical Trials
TYDAL Cardiovascular Disease Study
Learn about the TYDAL Trial, evaluating a potential new medication for the treatment of cardiovascular disease for people aged 18–75 with high cholesterol or triglycerides and are at risk for heart disease.
Click image to download PDF
Have high cholesterol or at risk for heart disease?
You may be eligible for a clinical trial evaluating a potential new medication for heart disease.
The study medication is designed to lower specific types of harmful fats in the blood that current medications don’t target effectively – with the aim of reducing heart attacks, strokes, and the need for procedures.
What’s Involved?
- 9-month study, with 8 clinic visits and 7 video/phone check-ins
- Injections every 2 or 4 weeks
- Health monitoring, blood tests, ECGs, and questionnaires
- All study-related care and medication at no cost
- Close support from our clinical team, and coordination with your regular doctor
Who Can Take Part?
- People aged 18–75
- Have high cholesterol or triglycerides
- Are at risk of cardiovascular disease
- Are currently on medication for cardiovascular risk or cardiovascular disease
Why Participate?
- Help develop a new treatment for heart health
- Access specialist care and monitoring
- Compensation for time & travel
See If You Qualify
For more info and to see if you qualify, please get in touch with us below.
Contact Us